Ir para o conteúdo principal

United States Últimas notícias

Todas as matérias desta categoria, das mais recentes às mais antigas.

Grafa

Intellia Therapeutics announces positive Phase 3 results for one-time HAE gene editing therapy

Intellia Therapeutics (NASDAQ:NTLA) today announced positive topline results from its pivotal Phase 3 HAELO clinical trial evaluating lonvoguran ziclumeran (lonvo-z), a one-time in vivo CRISPR-based gene editing therapy for patients with hereditary angioedema (HAE).

Leia mais: Intellia Therapeutics announces positive Phase 3 results for one-time HAE gene editing therapy
Grafa

Adagio Medical reports strong FULCRUM-VT trial data for vCLAS Ablation System

Adagio Medical Holdings (NASDAQ:ADGM) unveiled positive six-month results from its FULCRUM-VT clinical trial on Monday, providing the foundational data required for its forthcoming Food and Drug Administration (FDA) Premarket Approval application.

Leia mais: Adagio Medical reports strong FULCRUM-VT trial data for vCLAS Ablation System